Moritz Gartlgruber Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• A genome-wide MYCN synthetic lethal screen identifies inhibition of PRC2 as drug target in MYCN-amplified neuroblastoma cells — Poster Session 1 with wine & cheese